On the other hand, selective loading of exosomes with tumor-suppressive miRNAs, such as miR-124 seems to regulate immune responses from CD4 and CD8 T cells, leading to enhanced immunotherapeutic efficacy [57]. This evidence concerns the gene CD4 and neoplasm.